Mizuho Medy Co (TSE:4595) Current Deferred Revenue : 円0 Mil (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Mizuho Medy Co Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Mizuho Medy Co's current deferred revenue for the quarter that ended in Mar. 2024 was 円0 Mil.

Mizuho Medy Co Current Deferred Revenue Historical Data

The historical data trend for Mizuho Medy Co's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mizuho Medy Co Current Deferred Revenue Chart

Mizuho Medy Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Deferred Revenue

Get a 7-Day Free Trial

Mizuho Medy Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Current Deferred Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Mizuho Medy Co Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Mizuho Medy Co's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Mizuho Medy Co (TSE:4595) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mizuho Medy Co Ltd (TSE:4595) » Definitions » Current Deferred Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

4 Fujinoki-Machi, Saga Prefecture, Tosu, JPN, 841-0048

Website

http://www.mizuho-m.co.jp

Mizuho Medy Co Ltd engages in research and development, manufacture and distribution of in-vitro diagnostic products. The company provides immuno assay test products, such as influenza virus kits; Infectious diseases test kits; fecal occult blood test kits for detection of human hemoglobin and human transferrin in feces; and biochemical liquid stable reagents for professionals. It also offers HCG (midstream test), including digital p-check test for OTC. It also offers fruit tree virus test drugs to agricultural testing places.

Mizuho Medy Co (TSE:4595) Headlines

No Headlines